Lifecore Biomedical, Inc. \De\ (LFCR) Total Current Liabilities (2016 - 2025)
Lifecore Biomedical, Inc. \De\ has reported Total Current Liabilities over the past 15 years, most recently at $30.2 million for Q2 2025.
- For Q2 2025, Total Current Liabilities fell 22.37% year-over-year to $30.2 million; the TTM value through May 2025 reached $30.2 million, down 22.37%, while the annual FY2025 figure was $30.2 million, 22.37% down from the prior year.
- Total Current Liabilities for Q2 2025 was $30.2 million at Lifecore Biomedical, Inc. \De\, down from $31.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $195.6 million in Q4 2022 and troughed at $30.2 million in Q2 2025.
- A 5-year average of $81.1 million and a median of $40.4 million in 2023 define the central range for Total Current Liabilities.
- Biggest five-year swings in Total Current Liabilities: surged 73.37% in 2022 and later plummeted 80.19% in 2023.
- Year by year, Total Current Liabilities stood at $122.4 million in 2021, then skyrocketed by 59.83% to $195.6 million in 2022, then crashed by 79.42% to $40.3 million in 2023, then fell by 12.33% to $35.3 million in 2024, then dropped by 14.49% to $30.2 million in 2025.
- Business Quant data shows Total Current Liabilities for LFCR at $30.2 million in Q2 2025, $31.1 million in Q1 2025, and $35.3 million in Q4 2024.